MacLean Michael F
Insider CIK 1383731 · RNA Chief Financial Officer · AKCA Chief Financial Officer · CAMP Director · VERV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2026-04-01 | 2026-04-03 | 56,000 | — | $0 | 56,000 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 50,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 106,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 60,125 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 148,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 131,250 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 92,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 133,977 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 1,807 | $72.45 | $130.9K | 62,025 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 2,735 | $72.45 | $198.2K | 59,290 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 1,974 | $72.23 | $142.6K | 63,832 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-15 | 30,914 | $42.73 | $1.32M | 65,806 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 136,139 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 42,200 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 42,200 | — | $0 | 42,200 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 7,935 | $31.06 | $246.5K | 96,720 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 1,665 | $28.59 | $47.6K | 104,655 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 1,622 | $28.59 | $46.4K | 106,320 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 107,942 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 11,151 | $32.66 | $364.2K | 82,942 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-11-06 | 2024-11-08 | 65,182 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-11-06 | 2024-11-08 | 13,875 | — | $0 | 60,125 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 13,875 | $45.33 | $629.0K | 94,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 27,262 | $46.22 | $1.26M | 94,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-11-06 | 2024-11-08 | 65,182 | $8.82 | $574.9K | 159,275 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 65,182 | $45.33 | $2.95M | 94,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-11-06 | 2024-11-08 | 13,875 | $6.57 | $91.2K | 107,968 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-09-23 | 2024-09-23 | 11,510 | $44.00 | $506.4K | 96,355 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 121,355 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 107,865 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 136,139 | — | $0 | 136,139 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-18 | 2024-06-20 | 11,228 | $39.13 | $439.4K | 57,865 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-06-17 | 2024-06-20 | 25,000 | — | $0 | 82,865 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-06-17 | 2024-06-20 | 25,000 | — | $0 | 69,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-06-12 | 2024-06-14 | 104,245 | — | $0 | 65,182 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 104,245 | $35.72 | $3.72M | 44,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-06-12 | 2024-06-14 | 104,245 | $8.82 | $919.4K | 148,338 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-05-14 | 2024-05-16 | 75,000 | — | $0 | 169,427 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-05-14 | 2024-05-16 | 75,000 | $28.28 | $2.12M | 44,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-05-14 | 2024-05-16 | 75,000 | $8.82 | $661.5K | 119,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 40,000 | — | $0 | 244,427 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 40,000 | $24.52 | $980.8K | 44,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 40,000 | $8.82 | $352.8K | 84,093 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-01-22 | 2024-01-23 | 1,616 | $10.13 | $16.4K | 16,884 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-01-20 | 2024-01-23 | 106,000 | — | $0 | 106,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-01-20 | 2024-01-23 | 22,500 | — | $0 | 27,209 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-09-11 | 2023-09-12 | 74,000 | — | $0 | 74,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 26,642 | — | $0 | 26,642 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-16 | 7,000 | — | $0 | 7,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 148,000 | — | $0 | 148,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2023-01-20 | 2023-01-24 | 18,500 | — | $0 | 21,852 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-01-21 | 2022-03-15 | 131,250 | — | $0 | 131,250 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 47,664 | — | $0 | 47,664 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 92,000 | — | $0 | 92,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2020-01-15 | 2020-01-16 | 28,000 | — | $0 | 48,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2020-01-02 | 2020-01-03 | 57,000 | — | $0 | 57,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2019-09-19 | 2019-09-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2019-01-02 | 2019-01-04 | 83,000 | — | $0 | 83,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2018-01-02 | 2018-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2017-08-31 | 2017-09-05 | 332,708 | — | $0 | 332,708 | SEC↗ |